pd168393 and ekb 569

pd168393 has been researched along with ekb 569 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, R; Discafani, C; Floyd, MB; Greenberger, LM; Gruber, BC; Hallett, WA; Johnson, BD; Mamuya, N; Nilakantan, R; Overbeek, E; Rabindran, SK; Reich, MF; Rosfjord, EC; Shen, R; Shi, X; Tsou, HR; Wang, YF; Wissner, A; Ye, F	1

Other Studies

1 other study(ies) available for pd168393 and ekb 569

Article	Year
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epi Journal of medicinal chemistry, 2003, Jan-02, Volume: 46, Issue:1 Topics: Administration, Oral; Aminoquinolines; Aniline Compounds; Animals; Antineoplastic Agents; Cell Division; Enzyme Inhibitors; ErbB Receptors; Glutathione; Humans; Mice; Models, Molecular; Organic Chemicals; Phosphorylation; Receptor, ErbB-2; Structure-Activity Relationship; Substrate Specificity; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2003

Article

Year

Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epi

Journal of medicinal chemistry, 2003, Jan-02, Volume: 46, Issue:1

Topics: Administration, Oral; Aminoquinolines; Aniline Compounds; Animals; Antineoplastic Agents; Cell Division; Enzyme Inhibitors; ErbB Receptors; Glutathione; Humans; Mice; Models, Molecular; Organic Chemicals; Phosphorylation; Receptor, ErbB-2; Structure-Activity Relationship; Substrate Specificity; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003